1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Papillomavirus Infection: new trials by email Literature Review of Papillomavirus Infection trials Research Report on Papillomavirus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) - Advanced Solid Tumors, Genital Neoplasm, Female | Phase 1 / Phase 2 | Recruiting | Marengo Therapeutics, Inc. | 366 | 2023-01-04 | 2026-08-11 |
Abdominal Neoplasms (1) · Biliary Tract Neoplasms (1) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Epstein-Barr Virus Infections (1) · Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Genital Neoplasms, Female (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1)
Adenocarcinoma (1) · Biliary Tract Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Neuroendocrine (1) · Colonic Diseases (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Disease Attributes (1) · Esophageal Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1)
Docetaxel (1) · Irinotecan (1)
Marengo Therapeutics, Inc. (1)
Canada (1) · France (1) · Spain (1) · United States (1)
2023 (1)